Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

Detalles Bibliográficos
Autores principales: Chen, Qitong, Ouyang, Dengjie, Anwar, Munawar, Xie, Ning, Wang, Shouman, Fan, Peizhi, Qian, Liyuan, Chen, Gannong, Zhou, Enxiang, Guo, Lei, Gu, Xiaowen, Ding, Boni, Yang, Xiaohong, Liu, Liping, Deng, Chao, Xiao, Zhi, Li, Jing, Wang, Yunqi, Zeng, Shan, Hu, Jinhui, Zhou, Wei, Qiu, Bo, Wang, Zhongming, Weng, Jie, Liu, Mingwen, Li, Yi, Tang, Tiegang, Wang, Jianguo, Zhang, Hui, Dai, Bin, Tang, Wuping, Wu, Tao, Xiao, Maoliang, Li, Xiantao, Liu, Hailong, Li, Lai, Yi, Wenjun, Ouyang, Quchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974319/
https://www.ncbi.nlm.nih.gov/pubmed/33747972
http://dx.doi.org/10.3389/fonc.2021.661128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974319/
https://www.ncbi.nlm.nih.gov/pubmed/33747972
http://dx.doi.org/10.3389/fonc.2021.661128

Ejemplares similares